Market closed · data as of 27 Aug 2026 · source NSE via Alphave. Open the live chart →
Healthcare Global Enterprises (HCG) is a Bengaluru-headquartered specialty hospital chain focused on oncology — comprehensive cancer centres offering radiation therapy, medical oncology, surgical oncology and diagnostics across India — plus fertility centres under the Milann brand. Its hub-and-spoke network takes advanced cancer care (LINACs, PET-CT, robotics) to tier-2 cities. Private-equity ownership has shifted, with KKR agreeing in 2025 to acquire control from CVC.
India's largest dedicated cancer-care hospital network.
Healthcare Global Enterprises Ltd. is a constituent of NIFTY MICROCAP 250. See where it sits on the market heatmap →
Consolidated annual figures taken from Healthcare Global Enterprises Ltd.'s own filed statements — not estimates, and not restated by us. The most recent period shown is FY26 (year ended 31 Mar 2026).
| Metric | FY26 | FY25 | FY24 |
|---|---|---|---|
| EPS (basic, ₹) | 0.97 | 3.19 | 3.46 |
| Book value / share (₹) | 98.00 | 71.01 | 62.11 |
| Return on equity | 1.0% | 4.5% | 5.6% |
| Return on capital employed | 7.5% | 7.0% | 7.9% |
| Operating margin | 8.7% | 7.9% | 8.1% |
| Net margin | 0.9% | 2.2% | 2.2% |
| EBITDA | ₹466 Cr | ₹387 Cr | ₹330 Cr |
| Free cash flow | ₹55 Cr | ₹108 Cr | ₹99 Cr |
| Total debt | ₹910 Cr | ₹1,002 Cr | ₹673 Cr |
| Debt to equity | 0.65 | 1.01 | 0.78 |
| Interest coverage | 1.3 | 1.1 | 1.4 |
| Current ratio | 1.09 | 0.81 | 0.91 |
| Shares outstanding | 14,39,00,000 | 13,94,16,000 | 13,92,90,000 |
Open the full income statement, balance sheet and cash flow for HCG →
As disclosed for the quarter ended 30 Jun 2026.
Institutional ownership changes quarter to quarter. See daily FII and DII flows across the market →
Companies Alphave classifies in the same sub-sector, closest by market capitalisation.